• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Zhao J, Cui J, Huang D, Sun M, Ma Z, Chu Q, Liu Y, Wang Z, Li X, Li H, Zhang J, Sun J, Fei C, Wu YL. EP08.01-070 Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Squamous NSCLC. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
2
Zhao J, Wu J, Cui J, Wang L, Sun M, Gao B, Ma Z, Liu Y, Wang Z, Li X, Li H, Zhang J, Sun J, Fei C, Wu YL. EP08.01-071 Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Non-Squamous NSCLC. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
3
Qing Z, Zhao J, Gao B, Wang M, Chang J, Hu J, Li J, Zhang J, Zhang Q, Fei C, Wu YL. 1187TiP Phase III study of tislelizumab (TIS) with sitravatinib versus chemotherapy (chemo) in patients with locally advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with chemo and an anti-programmed cell death protein 1/ligand 1 (PD-[L]1) antibody. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
4
Jia B, Fei C, Ren J, Wang M, He JL, Xu ZC, Lu YF, Qi L, Liao YH, Qiao F. [Clinical study of digital six-axis external fixation frame based on CT data for tibiofibular fractures]. Zhonghua Wai Ke Za Zhi 2022;60:552-557. [PMID: 35658342 DOI: 10.3760/cma.j.cn112139-20211206-00580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
5
Zhou Q, Yu X, Gao B, Ma Z, Chu Q, Huang D, Zhao J, Day D, Body A, Pan H, Cui J, Li H, Sun J, Zhang J, Fei C, Wu YL. 2P Sitravatinib + tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.01.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]  Open
6
Goh J, Coward J, Gao B, Pires Da Silva I, Voskoboynik M, Day D, Body A, Gan H, Li X, Sun J, Fei C, Yang L, Millward M. 153P Safety/tolerability and antitumor activity of sitravatinib plus tislelizumab (TIS) in patients with advanced platinum-resistant ovarian cancer (PROC). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.10.172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]  Open
7
Gao B, Ma Z, Yu X, Huang D, Zhao J, Day D, Body A, Zhou Q, Chu Q, Pan H, Cui J, Chen C, Xiang X, Fei C, Yang L, Wu YL. 1284P Sitravatinib + tislelizumab in patients with anti-PD-(L)1 refractory/resistant metastatic NSCLC. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]  Open
8
Zhu X, Yangsen C, Yusheng Y, Xiaoping J, Xianzhi Z, Lingong J, Lei G, Yuxin S, Shuiwang Q, Fei C, Zhen J, Fang F, Houjun Z. PD-0421: Association of molecular profiles of pancreatic cancer with post-operative recurrence patterns. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00443-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
9
Zhu X, Yangsen C, Xianzhi Z, Yuxin S, Xiaoping J, Shuiwang Q, Fei C, Zhen J, Fang F, Lei G, Huojun Z. EP-1844 Re-irradiation with SBRT for pancreatic cancer: dose summation and toxicity. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32264-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
10
Zhu X, Yangsen C, Xianzhi Z, Yuxin S, Xiaoping J, Shuiwang Q, Fei C, Zhen J, Fang F, Lei G, Huojun Z. PO-0800 Radiation dose escalation in pancreatic cancer: a propensity-score matching study. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31220-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
11
Zhu X, Yangsen C, Xianzhi Z, Yuxin S, Xiaoping J, Shuiwang Q, Fei C, Zhen J, Fang F, Lei G, Huojun Z. OC-0382 Patterns of local failure after SBRT for pancreatic cancer: implications of target volume design. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30802-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
12
Zhu X, Yangsen C, Xianzhi Z, Yuxin S, Xiaoping J, Shuiwang Q, Fei C, Zhen J, Fang F, Zhen J, Huojun Z. EP-1409 QoL for Gem and ABX plus SBRT versus Gem and S-1 plus SBRT in metastatic pancreatic cancer. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31829-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
13
Zhu X, Dongchen S, Fuqi L, Xiaoping J, Yangsen C, Shuiwang Q, Fei C, Yuxin S, Fang F, Zhen J, Huojun Z. EP-1434: Patient reported outcomes after palliative radiotherapy for metastatic pancreatic cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31743-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
14
Zhu X, Dongchen S, Xiaoping J, Yangsen C, Yuxin S, Fei C, Shuiwang Q, Fang F, Zhen J, Huojun Z. PO-0763: The assessment of re-irradiation with stereotactic body radiation therapy for pancreatic cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31073-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
15
Zhu X, Fuqi L, Dongchen S, Xiaoping J, Yangsen C, Yuxin S, Fei C, Shuiwang Q, Fang F, Zhen J, Huojun Z. PO-0764: Treatment sequences and strategies for locally advanced unresectable pancreatic cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31074-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
16
Zhu X, Fuqi L, Dongchen S, Xiaoping J, Yangsen C, Yuxin S, Fei C, Shuiwang Q, Fang F, Zhen J, Huojun Z. EP-1420: Stereotactic body radiation therapy for resectable but medically inoperable pancreatic cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31729-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
17
Liew Z, Ritz B, Bonefeld-Jørgensen EC, Henriksen TB, Nohr EA, Bech BH, Fei C, Bossi R, von Ehrenstein OS, Streja E, Uldall P, Olsen J. Prenatal Exposure to Perfluorinated Chemicals and Risk of Congenital Cerebral Palsy in Children. Int J Epidemiol 2015. [DOI: 10.1093/ije/dyv096.202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
18
Fei C, Yao X, Sun Y, Gu X, Yu L, Lai X. Interleukin-10 polymorphisms associated with susceptibility to acute myeloid leukemia. Genet Mol Res 2015;14:925-30. [DOI: 10.4238/2015.february.2.15] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
19
Fei C. Effects of continue exhaustive running on rat cardiovascular ultrastructure, myocardial apoptosis and vessel function. Heart 2011. [DOI: 10.1136/heartjnl-2011-300867.716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
20
Zhao Z, Xue F, Zhang L, Zhang K, Fei C, Zheng W, Wang X, Wang M, Zhao Z, Meng X. The pharmacokinetics of nitazoxanide active metabolite (tizoxanide) in goats and its protein binding ability in vitro. J Vet Pharmacol Ther 2010;33:147-53. [PMID: 20444039 DOI: 10.1111/j.1365-2885.2009.01119.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
21
Yu B, Zhang M, Wu W, Chen L, Peng L, Bian G, Fu J, Fei C. Neoadjuvant chemoradiotherapy for locally advanced low-lying rectal cancer. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e15095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
22
Fei C, Guangsheng L, Fangyu W, Yujun W. Adsorption and recovery of Cu (II) with polysulphone microcapsules containing chitosan gel. J Microencapsul 2008;21:513-23. [PMID: 15513758 DOI: 10.1080/02652040410001729287] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
23
Yao Y, Fei C, Li Z. [A comparative study on wound healing treated by different doses of bovine basic fibroblast growth factor (bFGF)]. Zhonghua Shao Shang Za Zhi 2001;17:10-2. [PMID: 11876901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
24
Jones P, Villeneuve GB, Fei C, DeMarte J, Haggarty AJ, Nwe KT, Martin DA, Lebuis AM, Finkelstein JM, Gour-Salin BJ, Chan TH, Leyland-Jones BR. Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and beta-ionylideneacetamidobenzoates with retinoidal activity. J Med Chem 1998;41:3062-77. [PMID: 9685246 DOI: 10.1021/jm9801354] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
25
Zhu H, Wang Z, Fei C. [Valve replacement in children]. Zhonghua Wai Ke Za Zhi 1996;34:433-5. [PMID: 9590799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
26
Liu J, Wang Z, Fei C. [Surgical treatment of ventricular septal defect in 2,169 patients]. Zhonghua Wai Ke Za Zhi 1996;34:261-4. [PMID: 9387697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
27
Sardeo C, Fei C, Marlianici E, Giustiniani S. [Heparin-induced thrombocytopenia: review of the literature and description of 2 clinical cases]. G Ital Cardiol 1994;24:997-1002. [PMID: 7958642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
28
Dong JL, Fei C. [Analysis of 65 cases of abruptio placenta]. Zhonghua Fu Chan Ke Za Zhi 1992;27:144-6, 188. [PMID: 1395897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
29
Fei C, Walro JM. The re-expression of two myosin heavy chains in regenerated rat muscle spindles. Neurosci Lett 1989;97:75-9. [PMID: 2919012 DOI: 10.1016/0304-3940(89)90142-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
30
Fei C. [Changes in the plasma factor VIII related antigen level during pregnancy]. Zhonghua Fu Chan Ke Za Zhi 1982;17:229-31. [PMID: 6818000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA